TABLE 1

Clinical and biochemical features of 30 islet transplant recipients undergoing ultrasound and MRI evaluation

All subjectsSteatosisNo steatosisP
n30624
Age (years)43.7 (25–59)42.8 (32–59)43.9 (25–59)0.81
Male (%)13 (43)1 (16.7)12 (50)0.20
BMI (kg/m2)22.2 ± 3.023.6 ± 4.821.9 ± 2.40.42
GFR (ml/min)85 ± 20.688 ± 22.585 ± 20.60.74
AST (units/l)29 ± 9.626 ± 9.929 ± 9.50.53
Alkaline phosphatase (units/l)79 ± 26.975 ± 18.880 ± 28.90.71
Bilirubin (mg/dl)6.9 ± 2.85.8 ± 3.47.2 ± 2.60.29
Cholesterol (mmol/l)4.8 ± 0.84.9 ± 1.14.8 ± 0.70.71
Triglycerides (mmol/l)1.15 ± 0.641.76 ± 1.11.00 ± 0.350.15
LDL (mmol/l)2.65 ± 0.622.7 ± 0.82.6 ± 0.60.93
HDL (mmol/l)1.61 ± 0.431.42 ± 0.391.65 ± 0.430.24
Fasting glucose (mmol/l)6.82 ± 1.377.65 ± 1.656.61 ± 1.250.097
HbA1c (%)6.2 ± 0.676.4 ± 0.826.1 ± 0.640.52
C-peptide (nmol/l)0.65 ± 0.280.62 ± 0.380.66 ± 0.250.72
C-peptide:glucose ratio0.098 ± 0.040.085 ± 0.050.101 ± 0.0360.39
Exogenous insulin (%)9 (30)4 (67)5 (21)0.049
Statin therapy (%)19 (63)5 (83)14 (58)0.37
  • Data are means ± SD, n (%), or n (range). P, probability of a difference between steatosis and no steatosis.